Posts Tagged ‘Compound drug spending’
OIG Takes Notice as Compound Drug Use Skyrockets
The cost of compounded topical drugs to the country’s Medicare program has skyrocketed over the past several years, and that’s gotten the attention of a government watchdog agency. In a recently released report, The U.S. Department of Health and Human Services Office of Inspector General (OIG) found that Medicare Part D spending for these drugs…
Read More